QUIPAZINE-INDUCED STIMULUS-CONTROL IN THE RAT

被引:43
作者
WINTER, JC
机构
[1] Department of Pharmacology and Therapeutics, School of Medicine, State University of New York at Buffalo, Buffalo, 14214, New York
关键词
5-Hydroxytryptamine; LSD; Mescaline; Quipazine; Stimulus control;
D O I
10.1007/BF00426666
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The present investigation tested the hypothesis that quizapine, a drug thought to act directly or indirectly as an agonist at serotonergic (5-HT) receptors, mimics the stimulus properties of indoleamine and phenethylamine hallucinogens. In a group trained with mescaline (10 mg/kg) and saline in a singlelever response rate task, quipazine yielded intermediate results (58% mescaline-appropriate at 1 mg/kg), i.e., responding was fully appropriate for neither training condition. A second group was then trained with quipazine (3 mg/kg) and saline in a two-lever response choice task. Stimulus control was readily established with a mean of 22 sessions to achieve criterion performance (five consecutive sessions with at least 80% correct responses). When quipazine-trained rats were tested with LSD; responding was intermediate in nature (68% quipazine-appropriate) at a dose of 100 μg/kg but complete substitution was observed at 150 μg/kg (97% quipazine-appropriate). Similarly, subjects trained with LSD and saline in the two lever task and tested with quipazine responded in a fashion indistinguishable from the LSD training condition. The stimulus properties of quipazine alone and in cross tests in mescaline or LSD-trained subjects were blocked by the serotonergic antagonist, BC-105. Butaclamol, a dopaminergic antagonist, and the α-adrenergic antagonist, phentolamine, were without effect upon quipazine. The present data suggest that quipazine produces its stimulus effects by a serotonergic mechanism and that these effects are quite similar to those of LSD and mescaline. © 1979 Springer-Verlag.
引用
收藏
页码:265 / 269
页数:5
相关论文
共 26 条
[1]  
[Anonymous], 1971, STAT PRINCIPLES EXPT
[2]  
BARRY H, 1978, DRUG DISCRIMINATION, P3
[3]   ROLE OF SEROTONIN IN DISCRIMINATIVE STIMULUS PROPERTIES OF MESCALINE [J].
BROWNE, RG ;
HO, BT .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1975, 3 (03) :429-435
[4]  
CONGER JJ, 1951, Q J STUD ALCOHOL, V12, P1
[5]  
FREY LRG, 1978, DRUG DISCRIMINATION
[6]   POSSIBLE INTERACTION OF QUIPAZINE WITH CENTRAL DOPAMINE STRUCTURES [J].
GRABOWSK.M ;
ANTKIEWI.L ;
MICHALUK, J .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1974, 26 (01) :74-76
[7]  
HAMON M, 1976, N-S ARCH PHARMACOL, V294, P99, DOI 10.1007/BF00692790
[8]  
Heffter A., 1896, BER DTSCH CHEM GES, V29, P216, DOI DOI 10.1002/CBER.18960290145
[9]   MESCALINE AND LYSERGIC ACID DIETHYLAMIDE (LSD) AS DISCRIMINATIVE STIMULI [J].
HIRSCHHORN, ID ;
WINTER, JC .
PSYCHOPHARMACOLOGIA, 1971, 22 (01) :64-+
[10]  
HONG E, 1966, J PHARMACOL EXP THER, V153, P259